CJC-1295 without dac 5mg+IPA 5mg Kit
$125.00
(CJC-1295: 863288-34-0; Ipamorelin: 170851-70-4); supplier product specifications (Wuhan Boyuan Import & Export, Hebei Ganmiao New Material Tech); preclinical summaries on GHRH/GHS-R1a synergism.
Description
🧪 Product Profile: CJC-1295 without DAC (5mg) + IPA (5mg) Combination Kit
Product Name: CJC-1295 without DAC (5mg) + Ipamorelin (5mg) Research Kit
CAS Numbers: CJC-1295 (863288-34-0); Ipamorelin (170851-70-4)
Molecular Formulas: CJC-1295: C₁₅₂H₂₅₂N₄₄O₄₂; Ipamorelin: C₃₆H₅₁N₉O₆
Amino Acid Sequences:
- CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
- Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Purity: ≥98% per peptide (HPLC verified)
Formulation: Dual-vial lyophilized powder kit (5mg CJC-1295 without DAC + 5mg Ipamorelin)
🔬 Key Characteristics
This research kit combines two synergistic growth hormone secretagogues: CJC-1295 without DAC (a modified GHRH analog) and Ipamorelin (a selective GHRP). The formulation is designed to enhance growth hormone (GH) secretion through complementary mechanisms—CJC-1295 acts via GHRH receptor agonism, while Ipamorelin stimulates GHS-R1a—resulting in robust, pulsatile GH release without significant elevation of cortisol or prolactin in preclinical models.
⚙️ Mechanism of Action
- CJC-1295 without DAC: Binds to pituitary GHRH receptors, amplifying endogenous GH pulsatility by prolonging GHRH signaling. Lacks the DAC (drug affinity complex) moiety, resulting in a shorter half-life (~30 minutes) compared to CJC-1295 with DAC, requiring more frequent administration in research settings.
- Ipamorelin: Selective agonist of the ghrelin receptor (GHS-R1a), triggering GH release through calcium-dependent pathways while minimizing appetite stimulation and hormonal side effects (e.g., cortisol elevation) seen with other GHRPs like GHRP-6.
- Synergistic Effect: Co-administration enhances GH secretion by 2-3x compared to single-agent use, with preclinical data showing sustained IGF-1 elevation and improved anabolic-catabolic balance.
📊 Research Applications
- Metabolic Research: Studies on fat oxidation, lean muscle preservation, and insulin sensitivity in obesity or sarcopenia models.
- Endocrinology: Investigation of GH axis regulation, pituitary function, and age-related GH decline.
- Sports Physiology: Preclinical evaluation of muscle growth, recovery, and performance enhancement mechanisms.
- Combination Therapy Models: Research on peptide stacking strategies for optimized GH secretion kinetics.
💡 Product Features
- Dual-Vial Design: Separated lyophilized powders ensure stability; reconstitute individually with sterile solvent (e.g., bacteriostatic water) before mixing.
- Synergistic Ratio: 1:1 (w/w) formulation optimized for balanced GH stimulation without hormonal dysregulation.
- Purity: ≥98% HPLC purity per peptide, suitable for in vitro and animal model research.
- Storage Stability: Stable for 24 months at -20°C when lyophilized; reconstituted solutions require refrigeration and use within 72 hours.
⚠️ Disclaimer
For Research Use Only: Not approved for human or veterinary clinical applications. Handling requires adherence to peptide research protocols, including proper reconstitution, dosing, and biosafety measures.




